(DSS) DSS - Ratings and Ratios

Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US26253C1027

DSS: Packaging, Biotech, Finance, Securities, Lending, Healthcare

DSS Inc. (NYSE MKT:DSS), formerly known as Document Security Systems, Inc., is a diversified company operating across multiple sectors. The company specializes in product packaging, offering eco-friendly mailers, photo sleeves, custom folding cartons, and innovative 3-dimensional direct mail solutions. Additionally, DSS distributes nutritional and personal care products, emphasizing wellness. In the biotechnology sector, DSS invests in biohealth and biomedical companies, focusing on drug discovery and the treatment of neurological, oncological, and immune-related diseases. They are also pioneering open-air defense initiatives against airborne diseases like tuberculosis and influenza.

DSS further extends its reach into financial services by acquiring stakes in undervalued commercial banks, bank holding companies, and non-banking financial institutions. The company provides a range of financial services, including loan syndication, mortgage banking, trust and escrow services, and problem asset management. DSS also operates a real estate investment trust focused on healthcare properties. In the securities arena, they engage in investment management, securities trading, and digital asset brokerage. Despite their diverse operations, DSS faces challenges, as indicated by a negative Return on Equity of -85.07%, reflecting profitability struggles.

3-Month Forecast: - Technical Outlook: DSS shares are trading below their 20 and 50-day Simple Moving Averages (SMA) at 0.91 and 0.90, respectively, but above the 200-day SMA of 1.25. This indicates potential near-term weakness but longer-term support. The Average True Range (ATR) of 0.06 signals low volatility, suggesting price stability. - Fundamental Outlook: With a Price-to-Book (P/B) ratio of 0.15 and a negative Price-to-Earnings (P/E) ratio, DSS appears undervalued. However, the negative Return on Equity (RoE) of -85.07% raises concerns about profitability. The low average volume of 9,669 shares suggests limited market activity, which could impact liquidity. Conclusion: Over the next three months, DSS is expected to experience sideways trading with potential slight downside due to poor earnings and limited market activity. Investors should closely monitor the companys profitability improvements and market participation.

Additional Sources for DSS Stock

DSS Stock Overview

Market Cap in USD 9m
Sector Consumer Cyclical
Industry Packaging & Containers
GiC Sub-Industry Commercial Printing
IPO / Inception 1997-01-03

DSS Stock Ratings

Growth Rating -93.4
Fundamental -65.2
Dividend Rating 0.0
Rel. Strength -48.6
Analysts 5/5
Fair Price Momentum 0.36 USD
Fair Price DCF -

DSS Dividends

No Dividends Paid

DSS Growth Ratios

Growth Correlation 3m 38.4%
Growth Correlation 12m -91.7%
Growth Correlation 5y -98.7%
CAGR 5y -65.26%
CAGR/Max DD 5y -0.66
Sharpe Ratio 12m -1.45
Alpha -49.01
Beta -0.033
Volatility 60.54%
Current Volume 2.7k
Average Volume 20d 6.1k
What is the price of DSS stocks?
As of April 30, 2025, the stock is trading at USD 0.96 with a total of 2,666 shares traded.
Over the past week, the price has changed by +2.39%, over one month by +11.00%, over three months by +18.83% and over the past year by -45.00%.
Is DSS a good stock to buy?
No, based on ValueRay Fundamental Analyses, DSS (NYSE MKT:DSS) is currently (April 2025) a stock to sell. It has a ValueRay Fundamental Rating of -65.18 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSS as of April 2025 is 0.36. This means that DSS is currently overvalued and has a potential downside of -62.5%.
Is DSS a buy, sell or hold?
DSS has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy DSS.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for DSS stock price target?
According to ValueRays Forecast Model, DSS DSS will be worth about 0.4 in April 2026. The stock is currently trading at 0.96. This means that the stock has a potential downside of -59.38%.
Issuer Forecast Upside
Wallstreet Target Price 27.6 2775%
Analysts Target Price 1.5 56.3%
ValueRay Target Price 0.4 -59.4%